Literature DB >> 27630871

Comparison of Boric Acid and Combination Drug of Polymyxin, Neomycin and Hydrocortisone (polymyxin NH) in the Treatment of Acute Otitis Externa.

Soroush Amani1, Mohammad Moeini2.   

Abstract

INTRODUCTION: Acute otitis externa is an inflammation of the external auditory canal known as "swimmer's ear". Direct costs including medical treatment, painkillers, antibiotics, steroids or both and indirect costs are also remarkable. AIM: The aim of this study was to compare the effect of boric acid and polymyxin, neomycin and hydrocortisone composition in the treatment of acute otitis externa.
MATERIALS AND METHODS: This randomized clinical trial was carried out on 80 patients aged more than 17-year-old who were referred to Kashani hospital clinic with a diagnosis of acute otitis externa by otolaryngologist. The patients were randomly allocated to two groups (A: Boric acid and B: polymyxin NH ear drops) and Painkiller was prescribed and administered orally for all patients and in the presence of fever, cellulitis around the ears and neck adenopathy, broad-spectrum systemic antibiotics were used besides topical treatment. Symptoms of patients who were evaluated by a physician includes pain, discharge from the ear, swelling of the ear canal, auricle swelling, tenderness, and ear itching. In addition, pain was evaluated in patients and was recorded by Macgill Pain Questionnaire, in the first, third, seventh and tenth days.
RESULTS: Results showed that itching on third day (p=0.007) and swelling of the ear canal in the examination of the third day (p=0.006) and the seventh day (p=0.001) in the polymyxin NH group was more than those of boric acid group. Overall mean pain based on McGill questionnaire was 11.10±1.49 in boric acid group in the examination on the first day and was 4.05±0.22 in the examination on the tenth day and in the polymyxin NH group, it was 10.9±0.99 on the first day and 4.20±0.40 on the tenth day. In both groups, pain relief was the same and there was no significant difference between two groups (p=0.075).
CONCLUSION: The findings of this study showed slight differences in the effectiveness of the boric acid drug and combination of polymyxin, neomycin and hydrocortisone in the treatment of patients with acute otitis externa that is of clinical significance.

Entities:  

Keywords:  Drug therapy; Inflammation; Otolaryngology

Year:  2016        PMID: 27630871      PMCID: PMC5020241          DOI: 10.7860/JCDR/2016/17175.8073

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

Review 1.  Systematic review of topical antimicrobial therapy for acute otitis externa.

Authors:  Richard M Rosenfeld; Michael Singer; Jared M Wasserman; Sandra S Stinnett
Journal:  Otolaryngol Head Neck Surg       Date:  2006-04       Impact factor: 3.497

2.  A group III steroid solution without antibiotic components: an effective cure for external otitis.

Authors:  Per Emgård; Sten Hellström
Journal:  J Laryngol Otol       Date:  2005-05       Impact factor: 1.469

3.  Otitis externa: control of bacterial and mycological infections--a preliminary report.

Authors:  A I Glasgold; J E Boyd
Journal:  Eye Ear Nose Throat Mon       Date:  1973-03

4.  A comparison of the treatment of otitis externa with 'Otosporin' and aluminium acetate: a report from a services practice in Cyprus.

Authors:  I J Lambert
Journal:  J R Coll Gen Pract       Date:  1981-05

5.  The use of trichloroacetic acid in the treatment of acute external otitis.

Authors:  Ilias Kantas; Dimitrios G Balatsouras; Marinos Vafiadis; Maria Th Apostolidou; Agathokles Pournaras; Vasilis Danielidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-05       Impact factor: 2.503

6.  Efficacy of boric-complexed zinc and acetic-complexed zinc otic preparations for canine yeast otitis externa.

Authors:  Colleen L Mendelsohn; Craig E Griffin; Wayne S Rosenkrantz; Larry D Brown; Mona J Boord
Journal:  J Am Anim Hosp Assoc       Date:  2005 Jan-Feb       Impact factor: 1.023

7.  Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.

Authors:  Benjamin Torum; Stan L Block; Hugo Avila; Francisco Montiel; Axel Oliva; William Quintanilla; Frederick Duncanson; H Furman Cantrell; John Riefler; Ephraim Katz; Elyane Lombardy
Journal:  Clin Ther       Date:  2004-07       Impact factor: 3.393

8.  Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial.

Authors:  Frank A M van Balen; W Martijn Smit; Nicolaas P A Zuithoff; Theo J M Verheij
Journal:  BMJ       Date:  2003-11-22

Review 9.  Pain: past, present and future.

Authors:  R Melzack
Journal:  Can J Exp Psychol       Date:  1993-12

10.  A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain.

Authors:  Peter S Roland; Ramzi Younis; G Michael Wall
Journal:  Adv Ther       Date:  2007 May-Jun       Impact factor: 3.845

View more
  1 in total

1.  Histopathological and Inflammatory Features of Chronically Discharging Open Mastoid Cavities: Secondary Analysis of a Randomized Clinical Trial.

Authors:  Darius Henatsch; Sultan Alsulami; Adriaan M Duijvestijn; Jack P Cleutjens; Carine J Peutz-Kootstra; Robert J Stokroos
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-03-01       Impact factor: 6.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.